卡他莫拉菌（布兰汉菌属）BROβ-内酰胺酶：一种源于革兰氏阳性菌的脂蛋白？
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?
作者信息
Bootsma H J, Aerts P C, Posthuma G, Harmsen T, Verhoef J, van Dijk H, Mooi F R
机构信息
Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, University Hospital Utrecht, Utrecht, The Netherlands.
出版信息
J Bacteriol. 1999 Aug;181(16):5090-3. doi: 10.1128/JB.181.16.5090-5093.1999.
Abstract
In the past 20 years, BRO beta-lactamase-producing Moraxella catarrhalis strains have emerged. We show that BRO is expressed as a 33-kDa lipoprotein associated with the inner leaflet of the outer membrane. To our knowledge, this is the first description of a lipidated beta-lactamase in a gram-negative species.
摘要
在过去20年中，已出现产BROβ-内酰胺酶的卡他莫拉菌菌株。我们发现BRO作为一种与外膜内小叶相关的33 kDa脂蛋白表达。据我们所知，这是革兰氏阴性菌中脂化β-内酰胺酶的首次描述。
相似文献
1
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?卡他莫拉菌（布兰汉菌属）BROβ-内酰胺酶：一种源于革兰氏阳性菌的脂蛋白？
J Bacteriol. 1999 Aug;181(16):5090-3. doi: 10.1128/JB.181.16.5090-5093.1999.
2
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.卡他莫拉菌（布兰汉菌属）BROβ-内酰胺酶的分子特征
Antimicrob Agents Chemother. 1996 Apr;40(4):966-72. doi: 10.1128/AAC.40.4.966.
3
BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.卡他莫拉菌和莫拉克斯氏菌属莫拉克斯氏菌亚属的 BRO β-内酰胺酶，包括卡他莫拉菌、非液化莫拉克斯氏菌和腔隙莫拉克斯氏菌中通过接合进行染色体β-内酰胺酶转移的证据。
Antimicrob Agents Chemother. 1989 Nov;33(11):1845-54. doi: 10.1128/AAC.33.11.1845.
4
A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases.在产周质BRO - 1和BRO - 2β-内酰胺酶的卡他莫拉菌和非液化莫拉菌菌株中的一种膜结合前体β-内酰胺酶。
J Antimicrob Chemother. 1993 Feb;31(2):237-44. doi: 10.1093/jac/31.2.237.
5
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.对1994 - 1995年及1997 - 1998年期间从美国24个医疗中心获取的卡他莫拉菌（布兰汉菌）临床分离株中的β-内酰胺酶进行分子特征分析。
Antimicrob Agents Chemother. 2000 Feb;44(2):444-6. doi: 10.1128/AAC.44.2.444-446.2000.
6
Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.产BRO-1和BRO-2的卡他莫拉菌（布兰汉菌属）及非液化莫拉菌菌株中细胞结合型木瓜蛋白酶可溶性β-内酰胺酶的特性分析
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):313-21. doi: 10.1007/BF01962070.
7
[Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].[从携带菌儿童中分离的卡他莫拉菌菌株BROβ-内酰胺酶的分子特征分析]
Mikrobiyol Bul. 2004 Oct;38(4):335-40.
8
Natural insertion of the bro-1 β-lactamase gene into the gatCAB operon affects Moraxella catarrhalis aspartyl-tRNA(Asn) amidotransferase activity.自然插入的 bro-1 β-内酰胺酶基因到 gatCAB 操纵子影响卡他莫拉菌天冬氨酰-tRNA(Asn)氨酰基转移酶活性。
Microbiology (Reading). 2012 Sep;158(Pt 9):2363-2371. doi: 10.1099/mic.0.060095-0. Epub 2012 Jun 28.
9
Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan.日本分离的卡他莫拉菌（布兰汉菌属）的BRO酶特性及β-内酰胺酶转移
Chemotherapy. 1993 Mar-Apr;39(2):88-95. doi: 10.1159/000239108.
10
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.欧洲卡他莫拉菌分离株中BROβ-内酰胺酶的产生及对补体的抗性
J Clin Microbiol. 2002 Apr;40(4):1546-8. doi: 10.1128/JCM.40.4.1546-1548.2002.
引用本文的文献
1
A global perspective on the genomics of .关于……基因组学的全球视角。
你提供的原文“A global perspective on the genomics of.”似乎不完整，请补充完整以便我能更准确地翻译。
Microb Genom. 2025 Aug;11(8). doi: 10.1099/mgen.0.001488.
2
Understanding the population structure of using core genome multilocus sequence typing (cgMLST) and a life identification number (LIN) code classification system.使用核心基因组多位点序列分型（cgMLST）和生命识别号（LIN）编码分类系统来了解……的种群结构。
注：原文中“Understanding the population structure of ”后面缺少具体内容。
bioRxiv. 2025 May 4:2025.04.30.651387. doi: 10.1101/2025.04.30.651387.
3
The biogenesis of β-lactamase enzymes.β-内酰胺酶酶的生物发生。
Microbiology (Reading). 2022 Aug;168(8). doi: 10.1099/mic.0.001217.
4
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.金属β-内酰胺酶在多药耐药时代：从结构和机制到进化、传播和抑制剂设计。
Chem Rev. 2021 Jul 14;121(13):7957-8094. doi: 10.1021/acs.chemrev.1c00138. Epub 2021 Jun 15.
5
A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.用于预防中耳炎和 COPD 加重的卡他莫拉菌疫苗：当前进展和挑战的更新。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2322-2331. doi: 10.1080/21645515.2017.1356951.
6
Comparative Genomic Analyses of the Moraxella catarrhalis Serosensitive and Seroresistant Lineages Demonstrate Their Independent Evolution.卡他莫拉菌血清敏感和血清抗性谱系的比较基因组分析表明它们的独立进化。
Genome Biol Evol. 2016 Apr 6;8(4):955-74. doi: 10.1093/gbe/evw039.
7
Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei.类鼻疽伯克霍尔德菌的膜结合PenAβ-内酰胺酶
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1509-14. doi: 10.1128/AAC.02444-15.
8
B1-Metallo-β-Lactamases: Where Do We Stand?B1型金属β-内酰胺酶：我们目前的状况如何？
Curr Drug Targets. 2016;17(9):1029-50. doi: 10.2174/1389450116666151001105622.
9
Moraxella catarrhalis expresses a cardiolipin synthase that impacts adherence to human epithelial cells.卡他莫拉菌表达一种心磷脂合酶，该酶影响其与人上皮细胞的黏附。
J Bacteriol. 2014 Jan;196(1):107-20. doi: 10.1128/JB.00298-13. Epub 2013 Oct 18.
10
Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.利用 Chinchilla 模型评估卡他莫拉菌丝状血凝素样蛋白 MhaB1 和 MhaB2 的疫苗潜力。
PLoS One. 2013 Jul 2;8(7):e67881. doi: 10.1371/journal.pone.0067881. Print 2013.
本文引用的文献
1
ELECTRON MICROSCOPY OF PLASMOLYSIS IN ESCHERICHIA COLI.大肠杆菌质壁分离的电子显微镜观察
J Bacteriol. 1963 Mar;85(3):499-503. doi: 10.1128/jb.85.3.499-503.1963.
2
The cell-bound penicillinase of Bacillus cereus.蜡样芽孢杆菌的细胞结合青霉素酶。
J Gen Microbiol. 1956 Aug;15(1):154-69. doi: 10.1099/00221287-15-1-154.
3
Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.1994年和1995年美国723株卡他莫拉菌门诊临床分离株的抗菌药物耐药性流行情况：一项30中心全国性监测研究的结果
Antimicrob Agents Chemother. 1996 Dec;40(12):2884-6. doi: 10.1128/AAC.40.12.2884.
4
Improving structural integrity of cryosections for immunogold labeling.提高用于免疫金标记的冷冻切片的结构完整性。
Histochem Cell Biol. 1996 Jul;106(1):41-58. doi: 10.1007/BF02473201.
5
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.卡他莫拉菌（布兰汉菌属）BROβ-内酰胺酶的分子特征
Antimicrob Agents Chemother. 1996 Apr;40(4):966-72. doi: 10.1128/AAC.40.4.966.
6
A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases.在产周质BRO - 1和BRO - 2β-内酰胺酶的卡他莫拉菌和非液化莫拉菌菌株中的一种膜结合前体β-内酰胺酶。
J Antimicrob Chemother. 1993 Feb;31(2):237-44. doi: 10.1093/jac/31.2.237.
7
Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern.卡他莫拉菌分离株对β-内酰胺类抗生素的敏感性与β-内酰胺酶类型的关系
J Antimicrob Chemother. 1994 Feb;33(2):215-22. doi: 10.1093/jac/33.2.215.
8
Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.莫拉克斯氏菌引起肺炎球菌肺炎中青霉素中和作用的实验证据。
J Infect Dis. 1994 Dec;170(6):1613-6. doi: 10.1093/infdis/170.6.1613.
9
Membrane-bound penicillinases in Gram-positive bacteria.革兰氏阳性菌中的膜结合青霉素酶。
J Biol Chem. 1982 Apr 25;257(8):4490-5.
10
Beta-lactamase III of Bacillus cereus 569: membrane lipoprotein and secreted protein.蜡样芽孢杆菌569的β-内酰胺酶III：膜脂蛋白和分泌蛋白。
Biochemistry. 1983 Sep 27;22(20):4652-6. doi: 10.1021/bi00289a007.
Zotero 插件